Bill stops big firms from owning both drug insurers and drug stores.
S. 4509 — PBM Act · Filed by Elizabeth Warren (D-MA) · 3 cosponsors · Introduced May 13, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
The bill says PBMs and drug stores cannot be owned by the same firm. Firms that own both must sell one part within one year. The Federal Trade Commission, Justice Department, state attorneys general, and people can sue for breaks. Penalties include paying three times the harm, holding profits, and forced sales.
Who it affects
Patients and small drug stores gain from lower drug costs and fair play. Big health firms that own both PBMs and drug stores must sell one part. Taxpayers may save money on Medicaid and Medicare.
One thing to notice
The bill forces a split but does not stop PBMs from being owned by insurers. That is where some of the biggest conflicts happen.
From the analysis of the bill text, linked under Primary records below.
Where it stands
3 cosponsors: 2 Republicans, 1 Democrats.
- May 13, 2026 — Introduced · Congress.gov: “Introduced in Senate”
- May 13, 2026 — Referred to Senate Committee on the Judiciary · Congress.gov: “Read twice and referred to the Committee on the Judiciary”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
7 groups reported lobbying about this bill. They filed 13 reports from Jun 2026 to Sep 2026.
Those reports show $14,529,039 in lobbying spending. Each report lists about 34 bills. So that money was not all for this bill.
More groups named this bill than 83% of bills with any report.
Elizabeth Warren, who sponsored the bill, received $18,000 from PACs for the 2026 election.
- Pharmaceutical Care Management Association — $6,486,039 in 2 reports
- CVS Health (and Subsidiaries) — $5,610,000 in 2 reports
- National Association of Chain Drug Stores — $770,000 in 2 reports
- Blood Cancer United (fka the Leukemia & Lymphoma Society) — $710,000 in 2 reports
- National Community Pharmacists Association — $640,000 in 2 reports
Lobbying is legal. These reports show who lobbied about this bill, not what changed.
Words to know
- attorneys general — The top law officers for each state and the federal government.
- lobbying — Trying to influence lawmakers about a bill. Companies and groups pay people to do this.
- PACs — Groups that collect money and give it to candidates for office.
- sponsored — To sponsor a bill is to introduce it in Congress and put your name on it.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (12,783 characters) on Nov 14, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 17,910 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Sep 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Oct 21, 2026 · page rendered 2026-11-22.
“Bill stops big firms from owning both drug insurers and drug stores.” QuorumCivic. https://share.quorumcivic.app/bill/119/s4509/simple Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.